Nathan Wheeler is a biotech operations and program management executive with more than 15 years of experience leading cross-functional teams and advancing innovative therapies from early discovery through clinical validation. He currently drives strategy and operations at Pelage Pharmaceuticals, overseeing strategic planning, development execution, and organizational growth. Previously, Nathan led early-stage portfolio management at Allergan, guiding programs from discovery to clinical proof-of-concept across multiple therapeutic areas, and served as Head of Project & Portfolio Management at Visus Therapeutics, where he directed late-stage development and managed a diverse ophthalmology pipeline. Nathan holds a Master of Public Health (MPH) and is Project Management Professional (PMP) certified.
